ARCHIVES

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

This article is from The Cancer Letter archive.

Vol. 05 No. 05 | February 2, 1979

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

ASCO Foundation Renamed

February 18, 2011

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013